Top compounds associated with response to TLCD2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.046 0.2
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC 0.048 0.2
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.048 0.2
mRNA PLX4720 CCLE pan-cancer AAC 0.06 0.3
mRNA MLN2238 CTRPv2 pan-cancer AAC -0.044 0.3
mRNA nintedanib CTRPv2 pan-cancer AAC -0.047 0.3
mRNA Carboplatin CTRPv2 pan-cancer AAC -0.047 0.3
mRNA COL-3 CTRPv2 pan-cancer AAC -0.048 0.3
mRNA darinaparsin CTRPv2 pan-cancer AAC -0.066 0.3
mRNA ML210 CTRPv2 pan-cancer AAC -0.042 0.3
Download CSV